Clinical Trial Update: Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and efficacy study of allogeneic adipose-derived stem cells for lateral epicondylitis (tennis elbow) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lateral Epicondylitis

Drugs mentioned

• Allogeneic adipose-derived stem cells

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Tennis Elbow | Phase 1, Phase 2 | Status: COMPLETED